SARATOGA SPRINGS, NY – The Patient Experience Project (PEP), an EVERSANA™ agency, has announced the addition of Meaghan Kelly as Associate Director, Editorial. In this role, Kelly oversees editorial work for agency-wide accounts across multiple therapeutic areas. She is responsible for brand style management, and quality assurance of print and digital materials at all stages of production.

Kelly brings more than 14 years of editing and copywriting expertise to PEP. Her experience, which crosses consumer and professional healthcare advertising, includes managing industry and governmental compliance and quality assurance and control, brand launches into the managed markets and patient spaces, and project submissions to client medical, regulatory, and legal committees. Prior to joining PEP, Kelly was the managing editor at Health Communications (formerly MedAccess), a copywriter and editor for BayCare Health System, and the editorial assistant for the international peer-review journal Physiology & Behavior. She holds a Master of Arts in professional writing and editing from the University of Cincinnati and a Bachelor of Arts in English from the University of Florida.

“Meaghan’s depth of experience in healthcare marketing and commitment to editorial excellence make her a valuable addition to our department,” said Nora Wilder, Editorial Director at PEP.

For more information on PEP, visit



About the Patient Experience Project
PEP, an EVERSANA agency, is a full-service, patient-centric marketing and communications firm serving the healthcare, pharmaceutical, and biotechnology industries. PEP has offices in Saratoga Springs, New York, and Chicago, Illinois. PEP’s nationally recognized approach centers around collaboration with the foremost disease experts—patients themselves—to co-create authentic programs and content for patients, caregivers, and healthcare professionals. Learn more about career opportunities at

EVERSANA is the leading independent provider of global services to the life science industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product lifecycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers. The company serves more than 500 organizations, including innovative start-ups and established pharmaceutical companies, to advance life science services for a healthier world. To learn more about EVERSANA, visit or connect through LinkedIn and Twitter.